109 related articles for article (PubMed ID: 9922982)
1. Effect of roxatidine bismuth citrate (MX1) against acetylsalicylic acid- and indomethacin-induced gastric mucosal damage in rats.
Marazova K; Klouchek E; Popov A; Ivanov C; Krushkov I; Ichikawa T; Ishihara K; Hotta K
Methods Find Exp Clin Pharmacol; 1998 Oct; 20(8):667-72. PubMed ID: 9922982
[TBL] [Abstract][Full Text] [Related]
2. Gastroprotective effect of MX1 (a novel salt of the active metabolite of roxatidine with a complex of bismuth and citric acid) against stress ulcers in rats.
Marazova K; Klouchek E; Popov A; Ivanov CH; Krushkov I
J Pharm Pharmacol; 1997 Aug; 49(8):791-5. PubMed ID: 9379358
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, gastroprotective, antisecretory and anti-Helicobacter effect of N-[3-(3-(1-piperidinylmethyl) phenoxy)propyl]-hydroxyacetamide 2-hydroxypropane-1,2,3-tricarboxylate bismuth (3+) complex (MX1)-MX1.
Ivanov C; Petkov O; Petrov P; Taskov M; Athanassova R; Tsvetkova E; Kotsev V; Lyutakov G; Nikolov G; Savov E
J Pharm Pharmacol; 1996 Mar; 48(3):297-301. PubMed ID: 8737057
[TBL] [Abstract][Full Text] [Related]
4. Effects of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl] urea with potent gastric mucosal protective activity on acute gastric lesions and duodenal ulcers in rats.
Sekiguchi H; Hamada K; Taga F; Nishino K
Arzneimittelforschung; 1993 Feb; 43(2):134-8. PubMed ID: 8096133
[TBL] [Abstract][Full Text] [Related]
5. Structural requirements for roxatidine in the stimulant effect of rat gastric mucin synthesis and the participation of nitric oxide in this mechanism.
Ichikawa T; Ishihara K; Saigenji K; Hotta K
Br J Pharmacol; 1997 Nov; 122(6):1230-6. PubMed ID: 9401791
[TBL] [Abstract][Full Text] [Related]
6. Healing-promoting action of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl]urea with dual action on chronic gastric and duodenal ulcers induced by acetic acid in rats.
Sekiguchi H; Hamada K; Aijima H; Taga F; Uchida H; Nishino K
Arzneimittelforschung; 1993 Feb; 43(2):139-43. PubMed ID: 8096134
[TBL] [Abstract][Full Text] [Related]
7. Gastroprotective effect of ranitidine bismuth citrate is associated with increased mucus bismuth concentration in rats.
Tanaka S; Guth PH; Paulsen G; Kaunitz JD
Gut; 1996 Aug; 39(2):164-71. PubMed ID: 8977335
[TBL] [Abstract][Full Text] [Related]
8. Gastric anti-secretory, mucosal protective, anti-pepsin and anti-Helicobacter properties of ranitidine bismuth citrate.
Stables R; Campbell CJ; Clayton NM; Clitherow JW; Grinham CJ; McColm AA; McLaren A; Trevethick MA
Aliment Pharmacol Ther; 1993 Jun; 7(3):237-46. PubMed ID: 8364129
[TBL] [Abstract][Full Text] [Related]
9. Studies on the gastroprotective and ulcer-healing effects of colloidal bismuth subcitrate.
Konturek SJ; Radecki T; Piastucki I; Drozdowicz D
Digestion; 1987; 37 Suppl 2():8-15. PubMed ID: 3622948
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of roxatidine against indomethacin-induced small intestinal mucosal injury in rats.
Umegaki E; Yoda Y; Tokioka S; Murano M; Higuchi K
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S35-40. PubMed ID: 20586863
[TBL] [Abstract][Full Text] [Related]
11. Gastroprotective effect of simvastatin against indomethacin-induced gastric ulcer in rats: role of nitric oxide and prostaglandins.
Heeba GH; Hassan MK; Amin RS
Eur J Pharmacol; 2009 Apr; 607(1-3):188-93. PubMed ID: 19217901
[TBL] [Abstract][Full Text] [Related]
12. Studies on the antisecretory, gastric anti-ulcer and cytoprotective properties of glycine.
Tariq M; Al Moutaery AR
Res Commun Mol Pathol Pharmacol; 1997 Aug; 97(2):185-98. PubMed ID: 9344231
[TBL] [Abstract][Full Text] [Related]
13. Endothelin-1, interleukin-4 and nitric oxide synthase modulators of gastric mucosal injury by indomethacin: effect of antiulcer agents.
Slomiany BL; Piotrowski J; Slomiany A
J Physiol Pharmacol; 1999 Jun; 50(2):197-210. PubMed ID: 10424717
[TBL] [Abstract][Full Text] [Related]
14. Effects of a new histamine H2-receptor antagonist, Z-300, on gastric secretion and gastro-duodenal lesions in rats: comparison with roxatidine.
Okabe S; Takagi K; Igata H; Kato S; Shimosako K; Yamaji Y; Seiki M
Jpn J Pharmacol; 1992 Jul; 59(3):275-89. PubMed ID: 1359178
[TBL] [Abstract][Full Text] [Related]
15. Prevention of gastric mucosal lesions in rats by tri-potassium di-citrato bismuthate.
Malandrino S; Campagnoli G; Borsa M; Guidoboni R; Tonon GC
Arzneimittelforschung; 1984; 34(1):30-1. PubMed ID: 6367754
[TBL] [Abstract][Full Text] [Related]
16. [The effect of pyrimidine derivatives on experimental stomach ulcers in rats].
Ismagilova AF; Zarudiĭ FS; Lazareva DN; Ismagilova ZF; Savitskiĭ FP; Tropynina IuG; Davydova VA; Krivonogov VP
Eksp Klin Farmakol; 1998; 61(4):23-5. PubMed ID: 9783103
[TBL] [Abstract][Full Text] [Related]
17. Further evidence of the antiulcer activity of IAC, a novel free radical scavenger.
Carnevale G; Zanoli P; Zavatti M; Baraldi M
Pharmacology; 2011; 88(3-4):133-6. PubMed ID: 21912199
[TBL] [Abstract][Full Text] [Related]
18. Gastrocytoprotection by colloidal bismuth subcitrate (De-Nol) and sucralfate. Role of endogenous prostaglandins.
Konturek SJ; Radecki T; Piastucki I; Brzozowski T; Drozdowicz D
Gut; 1987 Feb; 28(2):201-5. PubMed ID: 3470240
[TBL] [Abstract][Full Text] [Related]
19. Effects of esomeprazole on healing of nonsteroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: Characterization of molecular mechanisms.
Fornai M; Colucci R; Antonioli L; Awwad O; Ugolini C; Tuccori M; Fulceri F; Natale G; Basolo F; Blandizzi C
Pharmacol Res; 2011 Jan; 63(1):59-67. PubMed ID: 20969958
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor (EGF) in the gastroprotective and ulcer healing actions of colloidal bismuth subcitrate (De-Nol) in rats.
Konturek SJ; Dembinski A; Warzecha Z; Bielanski W; Brzozowski T; Drozdowicz D
Gut; 1988 Jul; 29(7):894-902. PubMed ID: 3260885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
